Hattiesburg Clinic is participating in the COVID-19 Expanded Access Program, a nationwide clinical trial led by the Mayo Clinic. This trial aims to treat patients with severe COVID-19 disease by collecting convalescent plasma therapy from recovered COVID-19 patients and providing the therapy to hospitalized patients in critical condition.
If you have recovered from COVID-19 and are interested in participating in the COVID-19 Convalescent Plasma Trial by donating plasma, you must have:
- a formal COVID-19 diagnosis from a physician;
- recovered from the virus for 14 days with no symptoms; and
- a negative COVID-19 RNA swab